{"gene":"DLL1","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1995,"finding":"DLL1 is a mammalian transmembrane protein with tandem EGF-like repeats in its extracellular domain, closely related to Drosophila Delta, and functions as a ligand for Notch receptors in cell-to-cell signaling during embryogenesis, with expression in paraxial mesoderm and nervous system overlapping with Notch1.","method":"Molecular cloning, sequence analysis, in situ hybridization, expression mapping in mouse embryos","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — original identification with multiple orthogonal methods (cloning, sequence, in situ hybridization), foundational paper replicated by entire field","pmids":["7671806"],"is_preprint":false},{"year":2004,"finding":"WNT signaling, acting through LEF/TCF transcription factors in cooperation with TBX6, directly activates transcription from the Dll1 promoter in the tailbud and presomitic mesoderm; mutating either T-box or LEF/TCF binding sites in the Dll1 promoter abolishes reporter gene expression in transgenic embryos.","method":"Promoter reporter assays in vitro, transgenic mouse embryo reporter analysis, genetic epistasis with Wnt pathway components","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — combined in vitro promoter assay and transgenic in vivo validation with site-directed mutagenesis","pmids":["15545628"],"is_preprint":false},{"year":2005,"finding":"TBX6 directly binds to at least two of four putative Tbx6 binding sites within a Dll1 paraxial mesoderm enhancer in vitro, establishing Dll1 as a direct transcriptional target of Tbx6 in the presomitic mesoderm.","method":"Electrophoretic mobility shift assay (EMSA) for Tbx6 DNA binding, transgenic mouse analysis, genetic interaction studies","journal":"Genesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding assay plus genetic epistasis, single lab","pmids":["15986483"],"is_preprint":false},{"year":2005,"finding":"MAGI1, a scaffolding molecule, directly binds DLL1 and recruits it to cadherin-based adherens junctions (AJs), stabilizing DLL1 on the cell surface; in cultured AJ-forming fibroblasts, MAGI1 localizes DLL1 to AJs through this direct protein-protein interaction.","method":"Co-immunoprecipitation, pulldown assays, immunolocalization in developing spinal cord and cultured fibroblasts, surface stability assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal binding assay with localization and functional surface-stability data, multiple orthogonal methods in single lab","pmids":["15908431"],"is_preprint":false},{"year":2008,"finding":"Ubiquitination of DLL1 is not required for its endocytosis but is essential for recycling back to the cell surface; recycling is required for DLL1 to acquire high affinity for Notch1. A DLL1-DLL3 chimera (Dll1 ectodomain + Dll3 transmembrane/intracellular domain lacking lysines) can bind Notch1 but cannot induce transendocytosis of the Notch1 extracellular region, demonstrating that transendocytosis is required for Notch activation and depends on the DLL1 intracellular domain. DLL1 partially localizes to lipid microdomains, which are required for Notch signaling activation.","method":"Ubiquitination-defective DLL1 mutant analysis, chimeric DLL1-DLL3 construct, endocytosis/recycling assays, Notch1 binding assays, transendocytosis assay, lipid microdomain fractionation","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple complementary mechanistic constructs (ubiquitination mutant, chimeric ligand) with multiple orthogonal functional readouts in single rigorous study","pmids":["18676613"],"is_preprint":false},{"year":2009,"finding":"DLL1 is an essential Notch ligand in fetal arterial endothelial cells that activates Notch1 to maintain arterial identity; in the absence of DLL1, VEGFR2 and NRP1 are downregulated and COUP-TFII (a repressor of arterial identity) is upregulated, revealing a DLL1→Notch1→VEGF pathway axis.","method":"Endothelial-specific conditional knockout mice, immunofluorescence, in situ hybridization, cell culture Notch reporter assays, Nrp1 promoter RBPJκ-site analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with defined molecular phenotype and pathway placement, multiple downstream markers examined","pmids":["19144989"],"is_preprint":false},{"year":2011,"finding":"MT1-MMP (MMP14), expressed on bone marrow stromal cells, directly cleaves DLL1 on the cell surface, reducing Notch signaling in hematopoietic progenitor cells; this cleavage is required for normal B-lymphocyte development. Recombinant MT1-MMP cleaves a synthetic DLL1 peptide at the same site as on the cell surface.","method":"Co-culture of MT1-MMP-deficient BMSCs with hematopoietic progenitors, DAPT rescue experiments, Co-IP of MT1-MMP and DLL1, in vitro cleavage of synthetic DLL1 peptide by recombinant MT1-MMP, flow cytometry","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical cleavage assay with synthetic peptide plus co-IP interaction plus genetic rescue with Notch inhibitor, multiple orthogonal methods","pmids":["21572390"],"is_preprint":false},{"year":2011,"finding":"DLL1 and DLL4 together are the physiological Notch ligands in the intestinal epithelium; simultaneous inactivation of both leads to complete conversion of proliferating progenitors into goblet cells and loss of intestinal stem cells (Olfm4+, Lgr5+, Ascl2+), while single DLL1 inactivation causes only a moderate increase in goblet cells without loss of stem cells.","method":"Inducible gut-specific conditional knockout mice (Vil-Cre-ERT2), lineage tracing, immunofluorescence, in situ hybridization","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional double-KO with well-defined cellular phenotype, single vs double mutant comparison establishes functional redundancy and necessity","pmids":["21238454"],"is_preprint":false},{"year":2011,"finding":"DLL1 expression in the presomitic mesoderm is regulated by Cdx homeodomain transcription factors; Cdx members occupy the Dll1 promoter both in vivo (ChIP) and in vitro, and Cdx-Dll1 genetic interaction was confirmed in somitogenesis and goblet cell differentiation.","method":"Chromatin immunoprecipitation (ChIP), promoter occupancy assays, Cdx conditional knockout mice, genetic interaction analysis","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus genetic interaction, single lab, two orthogonal methods","pmids":["22015720"],"is_preprint":false},{"year":2011,"finding":"Elavl1/HuR binds to the 3' UTR of Dll1 mRNA in neuroepithelial cells during mitosis, stabilizing Dll1 mRNA; RNAi against Elavl1 reduces stability of Dll1-3'UTR-containing transcripts in mitosis-arrested cells and diminishes the capacity of brain precursors to trigger lateral inhibitory Notch signals to neighbors. Elavl1 heterozygous null mice show decreased Dll1 expression in developing brain.","method":"RNA immunoprecipitation (RIP), RNAi knockdown, mRNA stability assay, Elavl1 null-heterozygous mouse analysis, in vivo neurogenesis quantification in retina","journal":"Molecular Biology of the Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — RIP demonstrating direct mRNA interaction, functional validation by RNAi, in vivo genetic model, multiple orthogonal methods","pmids":["21346194"],"is_preprint":false},{"year":2013,"finding":"Dll1 protein is induced in activated neural stem cells (NSCs) in the adult subventricular zone, segregates asymmetrically to one daughter cell during mitosis, and is required to maintain quiescent NSCs; Dll1-expressing cells reside in close proximity to quiescent NSCs, suggesting a feedback niche signal from progeny to parent stem cells.","method":"Conditional Dll1 knockout mice, live imaging, immunofluorescence for asymmetric protein segregation during mitosis, BrdU/EdU labeling, flow cytometry","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined cellular phenotype, direct live imaging of asymmetric segregation, multiple orthogonal methods","pmids":["23695674"],"is_preprint":false},{"year":2014,"finding":"DLL4 but not DLL1 acts as an efficient cis-inhibitor of Notch signaling in cells co-expressing both ligand and receptor; both ligands have similar trans-activation potential, but the differential cis-inhibitory property of DLL4 contributes to context-dependent functional divergence. In vivo, endogenous Dll1 locus DLL4 knock-in mice show dominant somitogenesis defects.","method":"Notch transactivation co-culture assays in vitro, conditional overexpression from HPRT locus, DLL1-to-DLL4 knock-in mice (Dll1Dll4ki), vertebral column phenotype analysis","journal":"PLoS Genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro Notch activation assays with defined mechanistic distinction (cis vs trans), plus multiple in vivo genetic models confirming context-dependent divergence","pmids":["26114479"],"is_preprint":false},{"year":2014,"finding":"Serine and threonine phosphorylation sites in the intracellular domain of DLL1 were identified by mass spectrometry; phosphorylation requires membrane association and occurs sequentially, likely primed by protein kinase B. A phosphorylation-deficient DLL1 triple mutant is more stable but has reduced cell-surface levels, is more efficiently cleaved extracellularly, and activates Notch1 significantly less in co-culture assays. However, knock-in mice expressing the phosphorylation-deficient DLL1 develop normally, indicating compensation in vivo.","method":"Mass spectrometry phosphosite identification, site-directed mutagenesis, Notch1 co-culture activation assay, knock-in mouse generation, developmental phenotype analysis","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mass spectrometry identification plus mutagenesis plus in vitro functional assay plus in vivo knock-in, rigorous single study","pmids":["24449764"],"is_preprint":false},{"year":2013,"finding":"Over-expression of the DLL1 intracellular domain (DICD) in mouse embryonic stem cells does not block proliferation or stimulate neuronal differentiation, and ubiquitous DICD expression in transgenic mice produces no developmental phenotype, normal Notch target gene expression, and viable fertile adults. Mouse DICD enters the nucleus inefficiently, arguing against a reverse signaling function of the DLL1 intracellular domain in vivo.","method":"Transgenic mouse generation with ubiquitous DICD expression, ES cell transfection, Notch target gene analysis, nuclear localization assay","journal":"PLoS ONE","confidence":"High","confidence_rationale":"Tier 2 / Moderate — rigorous in vivo transgenic test of a specific mechanistic hypothesis (reverse signaling) with negative conclusion, multiple readouts","pmids":["24167636"],"is_preprint":false},{"year":2016,"finding":"Each individual EGF repeat in the extracellular domain of DLL1 is required for full Notch transactivation activity; mutations disrupting disulfide bridges in each EGF repeat reduce DLL1 activity toward both NOTCH1 and NOTCH2 in co-culture assays. In vivo, an allelic series of knock-in mice shows context-dependent sensitivity: some EGF repeat mutations affect only somite patterning (resembling spondylocostal dysostosis) while others affect multiple processes.","method":"EGF-repeat mutagenesis, HPRT single-copy transgene expression, Notch co-culture transactivation assay, knock-in mouse allelic series, vertebral column phenotyping","journal":"Genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis of all EGF repeats in vitro plus comprehensive in vivo allelic series, multiple orthogonal methods","pmids":["26801181"],"is_preprint":false},{"year":2016,"finding":"Mib1 ubiquitin ligase promotes the interaction between dynamin 2 and Snx18 in a ubiquitin ligase activity-dependent manner, thereby facilitating dynamin 2 recruitment to DLL1 and promoting DLL1 endocytosis and Notch signaling efficiency.","method":"Co-immunoprecipitation, ubiquitin ligase activity-dependent protein interaction assay, endocytosis assay for DLL1","journal":"Genes to Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP and functional endocytosis data, single lab, single paper","pmids":["26923255"],"is_preprint":false},{"year":2013,"finding":"SYNJ2BP (synaptojanin-2 binding protein) interacts with the PDZ binding motif of DLL1 (and DLL4) intracellular domain, but not with Jagged-1, enhances DLL1 protein stability, promotes Notch signaling in endothelial cells, and inhibits tip cell formation and sprouting angiogenesis.","method":"Yeast two-hybrid, Co-IP, DLL1/DLL4 protein stability assay, Notch target gene expression analysis, endothelial cell functional assays (migration, proliferation), in vivo vascular density in immunocompromised mice","journal":"Circulation Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding interaction identified and functional consequence on DLL1 stability demonstrated with multiple in vitro and in vivo readouts, single lab","pmids":["24025447"],"is_preprint":false},{"year":2018,"finding":"DLL1 is enriched in mammary gland stem cells (MaSCs) and mediates cross-talk with stromal macrophages; MaSC-expressed DLL1 activates Notch signaling in macrophages, increasing their expression of Wnt3, Wnt10A, and Wnt16, which feeds back to promote DLL1-expressing MaSC function. Conditional deletion of Dll1 reduced MaSC numbers and impaired ductal morphogenesis.","method":"Conditional Dll1 knockout mice, mammary transplantation assay, immunofluorescence, flow cytometry, Wnt ligand expression analysis in macrophages, co-culture experiments","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined cellular phenotype, identification of downstream pathway (Wnt ligands in macrophages), multiple orthogonal methods, high-impact venue","pmids":["29773667"],"is_preprint":false},{"year":2018,"finding":"Estrogen signaling stabilizes DLL1 protein by preventing its proteasomal and lysosomal degradation and inhibiting DLL1 ubiquitination in ERα+ breast cancer cells.","method":"Proteasomal/lysosomal inhibitor treatment, ubiquitination assay, DLL1 protein stability assay, DLL1 conditional knockout in breast cancer mouse models","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ubiquitination assay and pharmacological inhibitor experiments, single lab, two orthogonal methods","pmids":["30442981"],"is_preprint":false},{"year":2018,"finding":"DLL1 ectodomains dictate selective Notch receptor activation: DLL4 preferentially activates NOTCH1 over NOTCH2, whereas DLL1 is equally effective in activating NOTCH1 and NOTCH2. The discriminating potential lies in the region between the N-terminus and EGF repeat 3. In vivo, ectodomains dictate ligand function during somitogenesis, while during myogenesis even regions C-terminal to EGF3 are interchangeable.","method":"Chimeric DLL1/DLL4 ligand analysis, cellular co-culture Notch activation assays, biochemical binding studies, chimeric knock-in mice analysis in vivo","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic chimeric ligand approach combined with biochemical binding studies and in vivo genetic validation, multiple orthogonal methods","pmids":["30289388"],"is_preprint":false},{"year":2021,"finding":"MyoD directly activates transcription of Dll1 via E-box motifs in its regulatory region; Dll1 in turn activates Notch signaling in neighboring myoblasts (trans-activation) to prevent premature differentiation, while autonomously inhibiting Notch in Dll1-expressing cells to facilitate their own myogenic program. This MyoD-Dll1-Notch axis was validated by E-box mutant knock-in mice and CRISPR interference in human cells.","method":"ChIP for MyoD at Dll1 locus, E-box mutant knock-in mouse model, CRISPR-mediated interference, gain/loss-of-function studies in mouse and human cells, Notch reporter assays","journal":"PLoS Genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — ChIP, mutagenesis, in vivo knock-in, and human cell CRISPR validation across multiple orthogonal methods","pmids":["34370738"],"is_preprint":false},{"year":2021,"finding":"DLL1+ tumor cells activate Notch signaling in cancer-associated fibroblasts (CAFs), which increases Wnt ligand secretion from CAFs, leading to β-catenin-driven radioresistance and metastasis in breast cancer.","method":"Conditional Dll1 knockout and reporter mouse models, co-culture experiments, RNA-seq, ATAC-seq, pharmacological Notch/Wnt pathway inhibition","journal":"Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO mouse plus transcriptomic evidence plus pathway rescue experiments, single lab","pmids":["36007109"],"is_preprint":false},{"year":2021,"finding":"DLL1+ breast cancer tumor cells drive a chemoresistant phenotype via NF-κB activation downstream of DLL1; RNA-seq and ATAC-seq using reporter models and patient data showed NF-κB activation is downstream of DLL1. Pharmacological blocking of DLL1 or NF-κB completely sensitizes Dll1+ tumors to chemotherapy.","method":"Conditional Dll1 knockout and reporter mouse models, RNA-seq, ATAC-seq, NF-κB pathway inhibition, pharmacological DLL1 blockade","journal":"Nature Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with multi-omic pathway analysis, pharmacological rescue, single lab","pmids":["33462238"],"is_preprint":false},{"year":2022,"finding":"APE1 redox function activates NF-κB, which directly binds to and induces expression of DLL1 in esophageal adenocarcinoma cells in response to acidic bile salts (reflux conditions); elevated DLL1 then activates NOTCH1 signaling, promoting cancer stem-like properties.","method":"NF-κB binding to DLL1 promoter (ChIP), APE1 redox inhibitor experiments, DLL1 knockdown, Notch reporter assays, in vitro and transgenic mouse model validation","journal":"Gut","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP identifies direct NF-κB binding to DLL1 promoter, functional rescue experiments, single lab","pmids":["35750470"],"is_preprint":false},{"year":2022,"finding":"HUWE1 E3 ubiquitin ligase ubiquitinates and degrades N-Myc, which acts as a transcriptional activator of DLL1; thus HUWE1 suppresses the N-Myc→DLL1→NOTCH1 signaling axis to inhibit glioblastoma cell proliferation and invasion.","method":"Co-IP, ubiquitination assays, dCas9 synergistic activation, recombinant AAV-mediated HUWE1 overexpression, in vitro and orthotopic xenograft tumor models","journal":"Cancer Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ubiquitination assay plus pathway epistasis plus in vivo xenograft, single lab","pmids":["35848447"],"is_preprint":false},{"year":2022,"finding":"Dll1 expressed in the thymic epithelium can completely restore T-cell development in Dll4-deficient mice; Dll1 activates both NOTCH1 and NOTCH2 receptors to support T-cell development, in contrast to Dll4 which signals exclusively through NOTCH1 in the thymic environment.","method":"Foxn1-Cre conditional Dll4-knockout mice with Dll1 conditional transgenic rescue, bone marrow chimeras with Notch1- or Notch2-deficient hematopoietic cells, flow cytometry","journal":"Frontiers in Immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue experiment with conditional transgene plus receptor-specific chimera experiments, multiple orthogonal in vivo methods","pmids":["35371023"],"is_preprint":false},{"year":2025,"finding":"Site-specific O-glucose glycan elongation on NOTCH1 EGF10 (with hexose and Neu5Ac forming a 3'-sialyllactose-like structure, synthesized by B4GALT1 and ST3GAL4) significantly impacts DLL1- and DLL4-dependent NOTCH1 ligand binding and signal transduction; C4-2 position amino acid in the EGF domain is crucial for galactose elongation.","method":"Mass spectrometry glycan identification, mutagenesis (C4-2 position), Notch signaling assays, early T-cell development functional assays","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — mass spectrometry + mutagenesis + functional assay, single lab, novel finding not yet independently replicated","pmids":["41129232"],"is_preprint":false},{"year":2025,"finding":"Usp11 deubiquitinase sustains survival of marginal zone B cells by regulating ubiquitination of Notch ligands DLL1 and JAG2; Co-IP and ubiquitination experiments demonstrated that Usp11 physically interacts with DLL1 and JAG2 and prevents their ubiquitin-mediated degradation.","method":"Co-immunoprecipitation, ubiquitination assay, Usp11-/- knockout mice, flow cytometry, single-cell RNA sequencing","journal":"Cell Death & Disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus KO mouse model, single lab","pmids":["39904982"],"is_preprint":false},{"year":2025,"finding":"DLL1 recruits immunosuppressive PD-L1+ tumor-associated macrophages through the CCR3/CCL7 axis; tumor cell DLL1-mediated Notch signaling in macrophages maintains cancer stem cell activity. Combination of anti-DLL1 and anti-PD-L1 antibodies with tamoxifen reduced tumor growth and reprogrammed the immunosuppressive tumor microenvironment in mouse models and patient-derived explants.","method":"Conditional knockout mouse models, new immunocompetent breast cancer mouse models, antibody blockade experiments, patient-derived explants, flow cytometry, tumor growth analysis","journal":"Science Translational Medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO plus antibody blockade plus patient-derived explant validation, single lab, multiple orthogonal methods","pmids":["41191774"],"is_preprint":false},{"year":2010,"finding":"DLL1 mediates Notch activation across expression domain boundaries in the spinal cord (can signal to progenitors outside its own expression domain), whereas JAG1 can only activate Notch within V1 and dI6 progenitor domains; double Dll1;Jag1 conditional knockout embryos show stronger neurogenic phenotypes than single mutants, confirming functional compensation by Dll1 for Jag1 loss.","method":"Single and double conditional knockout mice (neuroepithelium-specific), neuronal subtype quantification, genetic epistasis","journal":"PLoS ONE","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional single and double KO comparison establishing differential spatial signaling range, multiple domain analysis","pmids":["21124801"],"is_preprint":false},{"year":2017,"finding":"DLL1-mediated Notch signaling in osteoblasts promotes proliferation of committed but immature osteoblasts while inhibiting their further differentiation into mature functional osteoblasts; osteoblast-specific DLL1 transgenic mice show severe suppression of bone metabolic turnover due to maturational arrest of osteoblasts impairing osteoblast-osteoclast coupling.","method":"Osteoblast-specific DLL1 transgenic mice, bone histomorphometry, osteoblast and osteoclast differentiation assays, bone remodeling marker analysis","journal":"Journal of Cellular Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — osteoblast-specific transgenic overexpression with defined cellular and tissue phenotype, single lab","pmids":["27735989"],"is_preprint":false},{"year":2012,"finding":"DLL1 activates Notch signaling predominantly through the Notch2 receptor in multiple myeloma cells on bone marrow stromal cells, and this signaling upregulates CYP1A1 (a drug-metabolizing cytochrome P450 enzyme) as a mechanism of bortezomib resistance; CYP1A1 inhibition or siRNA restored bortezomib sensitivity.","method":"Co-culture of myeloma cells with Dll1-expressing stromal cells, Notch receptor-specific analysis, CYP1A1 siRNA knockdown, pharmacological inhibition (α-naphthoflavone), in vivo 5T33MM mouse model","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — receptor specificity analysis, siRNA rescue, and in vivo validation, single lab","pmids":["23111325"],"is_preprint":false},{"year":2017,"finding":"Arp2/3 complex is required for DLL1 vesicular transport from cytoplasm to cell membrane; inhibition of Arp2/3 impedes DLL1 trafficking to the cell surface, preventing DLL1-mediated Notch1 activation and the maintenance of stem cell phenotype in glioma initiating cells.","method":"shRNA knockdown of DLL1 and Arp2/3 components, exogenous soluble DLL1 rescue experiment, vesicular transport imaging, CD133+ cell functional assays, intracranial xenograft model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — shRNA epistasis plus rescue with soluble DLL1, single lab, mechanistic interpretation of trafficking requirement","pmids":["28380416"],"is_preprint":false},{"year":2021,"finding":"C-terminal tagging of DLL1 protein with AcGFPHA or Strep/FLAG tags impairs DLL1 activity in vivo, causing vertebral column defects in homozygous knock-in mice, demonstrating that even small C-terminal additions can reduce DLL1 function during sensitive developmental processes such as somitogenesis.","method":"Endogenous knock-in tagging by homologous recombination, developmental phenotype analysis, Western blot protein detection, CHO cell functional assay","journal":"BMC Research Notes","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vivo knock-in with phenotypic readout, single lab, single paper establishing practical mechanistic constraint","pmids":["34583743"],"is_preprint":false}],"current_model":"DLL1 is a transmembrane Notch ligand whose extracellular EGF repeats (especially N-terminus to EGF3) engage NOTCH1 and NOTCH2 with equal potency (unlike DLL4 which preferentially activates NOTCH1); its activity depends on ubiquitination-driven endocytic recycling to acquire receptor-binding competency, correct vesicular trafficking to the plasma membrane (requiring Arp2/3), stabilization at adherens junctions via MAGI1 and PDZ-domain partners such as SYNJ2BP, and sequential intracellular phosphorylation primed by protein kinase B; extracellular shedding is negatively regulated by MT1-MMP cleavage; mRNA stability is controlled by HuR/Elavl1 during mitosis; DLL1 transcription is directly activated by WNT/LEF-TCF cooperating with TBX6/Tbx6, by Cdx factors, by MyoD (in muscle), and by NF-κB, while being post-translationally stabilized by estrogen (inhibiting ubiquitination) and destabilized by NEURL1B/Mib1-mediated ubiquitination and by Usp11-dependent deubiquitination; acting as a ligand it drives lateral inhibition and binary cell-fate decisions in diverse tissues (intestine, neural, vascular, muscle, pancreas, inner ear), activating downstream Hes/Hey targets through Notch1/2 in a context-dependent manner that is further modulated by O-glucose glycan elongation on NOTCH1 EGF10."},"narrative":{"mechanistic_narrative":"DLL1 is a mammalian transmembrane Notch ligand whose extracellular EGF-like repeats engage Notch receptors to drive cell-to-cell signaling and binary cell-fate decisions across many embryonic and adult tissues [PMID:7671806]. Its ectodomain dictates receptor selectivity: the region between the N-terminus and EGF repeat 3 confers the ability to activate NOTCH1 and NOTCH2 with equal efficiency, distinguishing it from DLL4 which preferentially activates NOTCH1, and each individual EGF repeat is required for full transactivation of both receptors [PMID:26801181, PMID:30289388]. Productive signaling requires DLL1 to be made receptor-binding competent: ubiquitination drives endocytic recycling needed to acquire high affinity for NOTCH1, and ligand-pulling transendocytosis of the Notch ectodomain depends on the DLL1 intracellular domain [PMID:18676613]. Surface availability and stability are tuned through trafficking and turnover—Arp2/3-dependent vesicular transport to the membrane [PMID:28380416], MAGI1-mediated recruitment to adherens junctions [PMID:15908431], SYNJ2BP binding to its PDZ motif [PMID:24025447], sequential intracellular phosphorylation primed by protein kinase B [PMID:24449764], MT1-MMP ectodomain shedding [PMID:21572390], and competing ubiquitination/deubiquitination by Mib1 and Usp11 [PMID:26923255, PMID:39904982]—whereas the intracellular domain does not mediate a reverse-signaling function in vivo [PMID:24167636]. DLL1 transcription is directly activated by WNT/LEF-TCF cooperating with TBX6, by Cdx factors, by MyoD in muscle, and by NF-κB, while HuR/Elavl1 stabilizes its mRNA during mitosis [PMID:15545628, PMID:22015720, PMID:34370738, PMID:35750470, PMID:21346194]. Functionally, DLL1 maintains intestinal and neural stem cells, arterial endothelial identity, T-cell development, and stem-cell/niche cross-talk, and partial loss-of-function mutations in EGF repeats produce somite-patterning defects resembling spondylocostal dysostosis [PMID:21238454, PMID:23695674, PMID:19144989, PMID:35371023, PMID:26801181].","teleology":[{"year":1995,"claim":"Established DLL1 as a mammalian transmembrane Notch ligand, answering whether the Drosophila Delta paradigm extends to vertebrate development.","evidence":"Molecular cloning, sequence analysis, and in situ hybridization in mouse embryos","pmids":["7671806"],"confidence":"High","gaps":["Did not resolve which Notch receptor(s) DLL1 preferentially activates","No mechanism of ligand activation or trafficking defined"]},{"year":2004,"claim":"Identified how DLL1 expression is positioned in the presomitic mesoderm by showing WNT/LEF-TCF cooperates with TBX6 to directly drive the Dll1 promoter.","evidence":"Promoter reporter assays plus transgenic mouse embryo reporters with site-directed mutagenesis of T-box and LEF/TCF sites","pmids":["15545628"],"confidence":"High","gaps":["Tissue-specific enhancers outside PSM not addressed","Did not establish direct TBX6 DNA contacts"]},{"year":2005,"claim":"Confirmed direct TBX6 binding to a Dll1 enhancer and identified MAGI1 as a junctional scaffold that stabilizes DLL1 at the cell surface, linking transcriptional control and surface presentation.","evidence":"EMSA for TBX6 binding; Co-IP, pulldown, immunolocalization, and surface-stability assays for MAGI1","pmids":["15986483","15908431"],"confidence":"Medium","gaps":["MAGI1 effect on signaling output not quantified","Single-lab findings"]},{"year":2008,"claim":"Defined the activation mechanism by showing ubiquitination-driven recycling makes DLL1 receptor-binding competent and that intracellular-domain-dependent transendocytosis is required for Notch activation.","evidence":"Ubiquitination-defective and DLL1-DLL3 chimeric constructs with endocytosis/recycling, binding, transendocytosis, and lipid microdomain assays","pmids":["18676613"],"confidence":"High","gaps":["Identity of the recycling-dependent affinity change unresolved","Specific ubiquitin ligase not yet assigned in this study"]},{"year":2009,"claim":"Placed DLL1 in a tissue pathway by showing it activates NOTCH1 to maintain arterial endothelial identity through downstream VEGF/NRP1 and COUP-TFII control.","evidence":"Endothelial-specific conditional knockout mice with immunofluorescence, in situ, and Notch reporter assays","pmids":["19144989"],"confidence":"High","gaps":["Direct vs indirect regulation of all downstream markers not fully separated"]},{"year":2010,"claim":"Distinguished DLL1 signaling range, showing it can activate Notch across expression-domain boundaries in the spinal cord and compensate for JAG1 loss.","evidence":"Single and double neuroepithelium-specific conditional knockouts with neuronal subtype quantification","pmids":["21124801"],"confidence":"High","gaps":["Molecular basis for differential signaling range vs JAG1 unknown"]},{"year":2011,"claim":"Mapped multiple regulatory inputs and tissue roles: Cdx transcriptional control, HuR-mediated mitotic mRNA stabilization, MT1-MMP shedding, and redundancy with DLL4 in intestinal stem-cell maintenance.","evidence":"ChIP and Cdx KO; RIP and Elavl1 mouse; MT1-MMP co-IP and synthetic-peptide cleavage; inducible gut-specific double KO with lineage tracing","pmids":["22015720","21346194","21572390","21238454"],"confidence":"High","gaps":["Interplay among these regulatory layers not integrated","Cdx and shedding findings are single-lab"]},{"year":2013,"claim":"Resolved whether the intracellular domain signals in reverse and revealed asymmetric DLL1 segregation in neural stem cells, plus SYNJ2BP as a stabilizing PDZ partner.","evidence":"Ubiquitous DICD transgenic mice and nuclear-localization assays; conditional Dll1 KO with live imaging; yeast two-hybrid and stability assays for SYNJ2BP","pmids":["24167636","23695674","24025447"],"confidence":"High","gaps":["DICD result is a negative in vivo conclusion that does not exclude subtle context-specific roles","SYNJ2BP finding single-lab"]},{"year":2014,"claim":"Linked surface stability, shedding, and phosphorylation, and separated cis-inhibition from trans-activation as a source of DLL1/DLL4 functional divergence.","evidence":"Mass spectrometry phosphosite mapping with mutants and knock-in mice; transactivation co-culture and DLL1-to-DLL4 knock-in mice","pmids":["24449764","26114479"],"confidence":"High","gaps":["Phospho-deficient mice develop normally, indicating in vivo compensation not understood","Kinase identity (PKB priming) inferred, not directly proven"]},{"year":2016,"claim":"Defined ectodomain structure-function by showing every EGF repeat contributes to activity and that Mib1 promotes DLL1 endocytosis via dynamin-2/Snx18 recruitment.","evidence":"Systematic EGF-repeat mutagenesis with knock-in allelic series; Co-IP and endocytosis assays for Mib1/dynamin-2/Snx18","pmids":["26801181","26923255"],"confidence":"High","gaps":["How individual EGF repeats map to receptor contacts not structurally resolved","Mib1/Snx18 mechanism single-lab"]},{"year":2017,"claim":"Established trafficking and tissue requirements: Arp2/3-dependent vesicular transport to the surface, and DLL1-Notch control of osteoblast maturation.","evidence":"shRNA epistasis with soluble-DLL1 rescue and transport imaging; osteoblast-specific transgenic mice with histomorphometry","pmids":["28380416","27735989"],"confidence":"Medium","gaps":["Arp2/3 requirement inferred from trafficking block, mechanism indirect","Osteoblast phenotype from overexpression, not loss-of-function"]},{"year":2018,"claim":"Defined receptor-selectivity determinants in the ectodomain and identified estrogen and stem-cell niche cross-talk as regulators of DLL1 stability and function.","evidence":"Chimeric ligand and biochemical binding studies with knock-in mice; ubiquitination/stability assays in ERα+ cells; conditional KO with mammary transplantation and macrophage co-culture","pmids":["30289388","30442981","29773667"],"confidence":"High","gaps":["Estrogen-to-ubiquitination link mechanistic intermediary unknown","Selectivity element between N-terminus and EGF3 not structurally mapped"]},{"year":2021,"claim":"Identified MyoD as a direct muscle transcriptional activator of Dll1 and characterized DLL1 cancer roles driving NF-κB chemoresistance and CAF-mediated Wnt/β-catenin radioresistance.","evidence":"ChIP, E-box mutant knock-in mice, and CRISPRi in human cells; conditional KO/reporter mice with RNA-seq, ATAC-seq, and pharmacological pathway inhibition","pmids":["34370738","33462238","36007109"],"confidence":"Medium","gaps":["NF-κB and CAF cancer mechanisms single-lab","Directness of NF-κB activation downstream of DLL1 not fully dissected"]},{"year":2022,"claim":"Expanded the regulatory network with NF-κB/APE1 and N-Myc/HUWE1 transcriptional control of DLL1, and showed DLL1 supports T-cell development via both NOTCH1 and NOTCH2.","evidence":"ChIP and redox-inhibitor experiments; Co-IP and ubiquitination assays with xenografts; conditional Dll4 KO with Dll1 rescue and Notch-receptor-deficient chimeras","pmids":["35750470","35848447","35371023"],"confidence":"Medium","gaps":["Cancer transcriptional axes single-lab","Receptor-usage context dependence not mechanistically explained"]},{"year":2025,"claim":"Connected NOTCH1 glycosylation to ligand binding and added Usp11 deubiquitination and immunosuppressive macrophage recruitment to the DLL1 functional repertoire.","evidence":"Mass spectrometry glycan mapping with mutagenesis; Co-IP/ubiquitination assays with Usp11 KO mice; conditional KO with antibody blockade and patient-derived explants","pmids":["41129232","39904982","41191774"],"confidence":"Medium","gaps":["Glycan finding not independently replicated","Usp11 and macrophage-axis findings single-lab"]},{"year":null,"claim":"How the multiple post-translational layers (recycling, phosphorylation, shedding, competing ubiquitination/deubiquitination) are integrated to set DLL1 signaling output in a given cell, and the structural basis of ectodomain receptor selectivity, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated quantitative model of DLL1 surface activation","No structure of DLL1 ectodomain bound to NOTCH1 vs NOTCH2","Compensation masking phospho-mutant phenotypes in vivo unexplained"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,14,19]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,4,19]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,4,32]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[4,32]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,5,7,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,25]}],"complexes":[],"partners":["NOTCH1","NOTCH2","MAGI1","SYNJ2BP","MMP14","MIB1","USP11"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O00548","full_name":"Delta-like protein 1","aliases":["Drosophila Delta homolog 1","Delta1","H-Delta-1"],"length_aa":723,"mass_kda":78.1,"function":"Transmembrane ligand protein of NOTCH1, NOTCH2 and NOTCH3 receptors that binds the extracellular domain (ECD) of Notch receptor in a cis and trans fashion manner (PubMed:11006133). Following transinteraction, ligand cells produce mechanical force that depends of a clathrin-mediated endocytosis, requiring ligand ubiquitination, EPN1 interaction, and actin polymerisation; these events promote Notch receptor extracellular domain (NECD) transendocytosis and triggers Notch signaling through induction of cleavage, hyperphosphorylation, and nuclear accumulation of the intracellular domain of Notch receptors (NICD) (By similarity). Is required for embryonic development and maintenance of adult stem cells in many different tissues and immune systeme; the DLL1-induced Notch signaling is mediated through an intercellular communication that regulates cell lineage, cell specification, cell patterning and morphogenesis through effects on differentiation and proliferation (PubMed:11581320). Plays a role in brain development at different level, namely by regulating neuronal differentiation of neural precursor cells via cell-cell interaction, most likely through the lateral inhibitory system in an endogenous level dependent-manner. During neocortex development, Dll1-Notch signaling transmission is mediated by dynamic interactions between intermediate neurogenic progenitors and radial glia; the cell-cell interactions are mediated via dynamic and transient elongation processes, likely to reactivate/maintain Notch activity in neighboring progenitors, and coordinate progenitor cell division and differentiation across radial and zonal boundaries. During cerebellar development, regulates Bergmann glial monolayer formation and its morphological maturation through a Notch signaling pathway. At the retina and spinal cord level, regulates neurogenesis by preventing the premature differentiation of neural progenitors and also by maintaining progenitors in spinal cord through Notch signaling pathway. Also controls neurogenesis of the neural tube in a progenitor domain-specific fashion along the dorsoventral axis. Maintains quiescence of neural stem cells and plays a role as a fate determinant that segregates asymmetrically to one daughter cell during neural stem cells mitosis, resulting in neuronal differentiation in Dll1-inheriting cell. Plays a role in immune systeme development, namely the development of all T-cells and marginal zone (MZ) B-cells (By similarity). Blocks the differentiation of progenitor cells into the B-cell lineage while promoting the emergence of a population of cells with the characteristics of a T-cell/NK-cell precursor (PubMed:11581320). Also plays a role during muscle development. During early development, inhibits myoblasts differentiation from the medial dermomyotomal lip and later regulates progenitor cell differentiation. Directly modulates cell adhesion and basal lamina formation in satellite cells through Notch signaling. Maintains myogenic progenitors pool by suppressing differentiation through down-regulation of MYOD1 and is required for satellite cell homing and PAX7 expression. During craniofacial and trunk myogenesis suppresses differentiation of cranial mesoderm-derived and somite-derived muscle via MYOD1 regulation but in cranial mesoderm-derived progenitors, is neither required for satellite cell homing nor for PAX7 expression. Also plays a role during pancreatic cell development. During type B pancreatic cell development, may be involved in the initiation of proximodistal patterning in the early pancreatic epithelium. Stimulates multipotent pancreatic progenitor cells proliferation and pancreatic growth by maintaining HES1 expression and PTF1A protein levels. During fetal stages of development, is required to maintain arterial identity and the responsiveness of arterial endothelial cells for VEGFA through regulation of KDR activation and NRP1 expression. Controls sprouting angiogenesis and subsequent vertical branch formation through regulation on tip cell differentiation. Negatively regulates goblet cell differentiation in intestine and controls secretory fat commitment through lateral inhibition in small intestine. Plays a role during inner ear development; negatively regulates auditory hair cell differentiation. Plays a role during nephron development through Notch signaling pathway. Regulates growth, blood pressure and energy homeostasis (By similarity)","subcellular_location":"Apical cell membrane; Cell junction, adherens junction; Membrane raft","url":"https://www.uniprot.org/uniprotkb/O00548/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DLL1","classification":"Not Classified","n_dependent_lines":11,"n_total_lines":1208,"dependency_fraction":0.009105960264900662},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DLL1","total_profiled":1310},"omim":[{"mim_id":"618709","title":"NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES; NEDBAS","url":"https://www.omim.org/entry/618709"},{"mim_id":"618024","title":"NOTCH2 N-TERMINAL-LIKE B; NOTCH2NLB","url":"https://www.omim.org/entry/618024"},{"mim_id":"615893","title":"NEURALIZED E3 UBIQUITIN PROTEIN LIGASE 1B; NEURL1B","url":"https://www.omim.org/entry/615893"},{"mim_id":"615544","title":"PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6","url":"https://www.omim.org/entry/615544"},{"mim_id":"615532","title":"ENDOPLASMIC RETICULUM MEMBRANE-ASSOCIATED RNA DEGRADATION PROTEIN; ERMARD","url":"https://www.omim.org/entry/615532"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":42.7}],"url":"https://www.proteinatlas.org/search/DLL1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O00548","domains":[{"cath_id":"2.60.40.3510","chopping":"17-189","consensus_level":"high","plddt":86.6807,"start":17,"end":189}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00548","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00548-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00548-F1-predicted_aligned_error_v6.png","plddt_mean":75.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DLL1","jax_strain_url":"https://www.jax.org/strain/search?query=DLL1"},"sequence":{"accession":"O00548","fasta_url":"https://rest.uniprot.org/uniprotkb/O00548.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00548/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00548"}},"corpus_meta":[{"pmid":"23000963","id":"PMC_23000963","title":"Dll1+ secretory progenitor cells revert to stem cells upon crypt damage.","date":"2012","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23000963","citation_count":633,"is_preprint":false},{"pmid":"7671806","id":"PMC_7671806","title":"Transient and restricted expression during mouse embryogenesis of Dll1, a murine gene closely related to Drosophila Delta.","date":"1995","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7671806","citation_count":406,"is_preprint":false},{"pmid":"19144989","id":"PMC_19144989","title":"DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19144989","citation_count":384,"is_preprint":false},{"pmid":"21238454","id":"PMC_21238454","title":"Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells.","date":"2011","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/21238454","citation_count":352,"is_preprint":false},{"pmid":"16141228","id":"PMC_16141228","title":"The Notch ligands DLL1 and JAG2 act synergistically to regulate hair cell development in the mammalian inner ear.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16141228","citation_count":228,"is_preprint":false},{"pmid":"29773667","id":"PMC_29773667","title":"Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche.","date":"2018","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29773667","citation_count":164,"is_preprint":false},{"pmid":"15545628","id":"PMC_15545628","title":"WNT signaling, in synergy with T/TBX6, controls Notch signaling by regulating Dll1 expression in the presomitic mesoderm of mouse embryos.","date":"2004","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/15545628","citation_count":147,"is_preprint":false},{"pmid":"20548034","id":"PMC_20548034","title":"Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20548034","citation_count":132,"is_preprint":false},{"pmid":"23695674","id":"PMC_23695674","title":"Dll1 maintains quiescence of adult neural stem cells and segregates asymmetrically during mitosis.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/23695674","citation_count":114,"is_preprint":false},{"pmid":"23699523","id":"PMC_23699523","title":"Dynamic interactions between intermediate neurogenic progenitors and radial glia in embryonic mouse neocortex: potential role in Dll1-Notch signaling.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23699523","citation_count":82,"is_preprint":false},{"pmid":"30442981","id":"PMC_30442981","title":"Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30442981","citation_count":78,"is_preprint":false},{"pmid":"12900443","id":"PMC_12900443","title":"Feedback loops comprising Dll1, Dll3 and Mesp2, and differential involvement of Psen1 are essential for rostrocaudal patterning of somites.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12900443","citation_count":77,"is_preprint":false},{"pmid":"18676613","id":"PMC_18676613","title":"The intracellular region of Notch ligands Dll1 and Dll3 regulates their trafficking and signaling activity.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18676613","citation_count":71,"is_preprint":false},{"pmid":"33462238","id":"PMC_33462238","title":"Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33462238","citation_count":60,"is_preprint":false},{"pmid":"21825014","id":"PMC_21825014","title":"Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21825014","citation_count":60,"is_preprint":false},{"pmid":"15908431","id":"PMC_15908431","title":"MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15908431","citation_count":58,"is_preprint":false},{"pmid":"31353024","id":"PMC_31353024","title":"Haploinsufficiency of the Notch Ligand DLL1 Causes Variable Neurodevelopmental Disorders.","date":"2019","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31353024","citation_count":57,"is_preprint":false},{"pmid":"32059775","id":"PMC_32059775","title":"Jag1 Modulates an Oscillatory Dll1-Notch-Hes1 Signaling Module to Coordinate Growth and Fate of Pancreatic Progenitors.","date":"2020","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/32059775","citation_count":57,"is_preprint":false},{"pmid":"22096075","id":"PMC_22096075","title":"Ptf1a-mediated control of Dll1 reveals an alternative to the lateral inhibition mechanism.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22096075","citation_count":55,"is_preprint":false},{"pmid":"19389377","id":"PMC_19389377","title":"Dll1 and Dll4 function sequentially in the retina and pV2 domain of the spinal cord to regulate neurogenesis and create cell diversity.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19389377","citation_count":53,"is_preprint":false},{"pmid":"25468943","id":"PMC_25468943","title":"Spatiotemporal oscillations of Notch1, Dll1 and NICD are coordinated across the mouse PSM.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25468943","citation_count":51,"is_preprint":false},{"pmid":"15986483","id":"PMC_15986483","title":"Dll1 is a downstream target of Tbx6 in the paraxial mesoderm.","date":"2005","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/15986483","citation_count":50,"is_preprint":false},{"pmid":"34035167","id":"PMC_34035167","title":"DLL1 orchestrates CD8+ T cells to induce long-term vascular normalization and tumor regression.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34035167","citation_count":47,"is_preprint":false},{"pmid":"30048987","id":"PMC_30048987","title":"MiR-34a Enhances Chondrocyte Apoptosis, Senescence and Facilitates Development of Osteoarthritis by Targeting DLL1 and Regulating PI3K/AKT Pathway.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30048987","citation_count":47,"is_preprint":false},{"pmid":"28281638","id":"PMC_28281638","title":"MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28281638","citation_count":46,"is_preprint":false},{"pmid":"23111325","id":"PMC_23111325","title":"Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23111325","citation_count":45,"is_preprint":false},{"pmid":"21572390","id":"PMC_21572390","title":"MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell development.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21572390","citation_count":45,"is_preprint":false},{"pmid":"26404003","id":"PMC_26404003","title":"Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.","date":"2015","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26404003","citation_count":45,"is_preprint":false},{"pmid":"24025447","id":"PMC_24025447","title":"Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.","date":"2013","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/24025447","citation_count":39,"is_preprint":false},{"pmid":"26114479","id":"PMC_26114479","title":"Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26114479","citation_count":35,"is_preprint":false},{"pmid":"30289388","id":"PMC_30289388","title":"The ectodomains determine ligand function in vivo and selectivity of DLL1 and DLL4 toward NOTCH1 and NOTCH2 in vitro.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30289388","citation_count":31,"is_preprint":false},{"pmid":"28380416","id":"PMC_28380416","title":"Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28380416","citation_count":31,"is_preprint":false},{"pmid":"36007109","id":"PMC_36007109","title":"Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer.","date":"2022","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/36007109","citation_count":31,"is_preprint":false},{"pmid":"35750470","id":"PMC_35750470","title":"Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma.","date":"2022","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/35750470","citation_count":30,"is_preprint":false},{"pmid":"24860699","id":"PMC_24860699","title":"Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine.","date":"2014","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/24860699","citation_count":29,"is_preprint":false},{"pmid":"23284862","id":"PMC_23284862","title":"Delta-like ligand (DLL)1 expression in early mouse decidua and its localization to uterine natural killer cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23284862","citation_count":29,"is_preprint":false},{"pmid":"30538222","id":"PMC_30538222","title":"CCN3 and DLL1 co-regulate osteogenic differentiation of mouse embryonic fibroblasts in a Hey1-dependent manner.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30538222","citation_count":27,"is_preprint":false},{"pmid":"32029480","id":"PMC_32029480","title":"DLL1- and DLL4-Mediated Notch Signaling Is Essential for Adult Pancreatic Islet Homeostasis.","date":"2020","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/32029480","citation_count":26,"is_preprint":false},{"pmid":"35848447","id":"PMC_35848447","title":"The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.","date":"2022","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35848447","citation_count":26,"is_preprint":false},{"pmid":"21124801","id":"PMC_21124801","title":"Two Notch ligands, Dll1 and Jag1, are differently restricted in their range of action to control neurogenesis in the mammalian spinal cord.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21124801","citation_count":25,"is_preprint":false},{"pmid":"26826998","id":"PMC_26826998","title":"Effect of Jagged-1 and Dll-1 on osteogenic differentiation by stem cells from human exfoliated deciduous teeth.","date":"2016","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/26826998","citation_count":25,"is_preprint":false},{"pmid":"26211721","id":"PMC_26211721","title":"Increased Serum Levels of the Notch Ligand DLL1 are Associated with Diastolic Dysfunction, Reduced Exercise Capacity, and Adverse Outcome in Chronic Heart Failure.","date":"2015","source":"Journal of cardiac failure","url":"https://pubmed.ncbi.nlm.nih.gov/26211721","citation_count":25,"is_preprint":false},{"pmid":"25041739","id":"PMC_25041739","title":"Dengue virus up-regulates expression of notch ligands Dll1 and Dll4 through interferon-β signalling pathway.","date":"2015","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25041739","citation_count":24,"is_preprint":false},{"pmid":"25220152","id":"PMC_25220152","title":"Divergent and conserved roles of Dll1 signaling in development of craniofacial and trunk muscle.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25220152","citation_count":23,"is_preprint":false},{"pmid":"34370738","id":"PMC_34370738","title":"Feedback regulation of Notch signaling and myogenesis connected by MyoD-Dll1 axis.","date":"2021","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34370738","citation_count":22,"is_preprint":false},{"pmid":"28900388","id":"PMC_28900388","title":"DISC1 Regulates the Proliferation and Migration of Mouse Neural Stem/Progenitor Cells through Pax5, Sox2, Dll1 and Neurog2.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28900388","citation_count":21,"is_preprint":false},{"pmid":"21346194","id":"PMC_21346194","title":"Stabilization of Dll1 mRNA by Elavl1/HuR in neuroepithelial cells undergoing mitosis.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21346194","citation_count":21,"is_preprint":false},{"pmid":"32044957","id":"PMC_32044957","title":"Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.","date":"2020","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32044957","citation_count":21,"is_preprint":false},{"pmid":"23499991","id":"PMC_23499991","title":"Sustained vs. oscillating expressions of Ngn2, Dll1 and Hes1: a model of neural differentiation of embryonic telencephalon.","date":"2013","source":"Journal of theoretical biology","url":"https://pubmed.ncbi.nlm.nih.gov/23499991","citation_count":21,"is_preprint":false},{"pmid":"21752535","id":"PMC_21752535","title":"Overexpression of Notch ligand Dll1 in B16 melanoma cells leads to reduced tumor growth due to attenuated vascularization.","date":"2011","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/21752535","citation_count":21,"is_preprint":false},{"pmid":"28474304","id":"PMC_28474304","title":"The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy.","date":"2017","source":"Journal of cardiovascular translational research","url":"https://pubmed.ncbi.nlm.nih.gov/28474304","citation_count":20,"is_preprint":false},{"pmid":"15979417","id":"PMC_15979417","title":"Identification of Dll1 (Delta1) target genes during mouse embryogenesis using differential expression profiling.","date":"2005","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15979417","citation_count":20,"is_preprint":false},{"pmid":"27735989","id":"PMC_27735989","title":"Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27735989","citation_count":18,"is_preprint":false},{"pmid":"19562077","id":"PMC_19562077","title":"Dll1 haploinsufficiency in adult mice leads to a complex phenotype affecting metabolic and immunological processes.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19562077","citation_count":16,"is_preprint":false},{"pmid":"31233755","id":"PMC_31233755","title":"MIR148A family regulates cardiomyocyte differentiation of human embryonic stem cells by inhibiting the DLL1-mediated NOTCH signaling pathway.","date":"2019","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/31233755","citation_count":15,"is_preprint":false},{"pmid":"22561395","id":"PMC_22561395","title":"Genetic and functional evaluation of the role of DLL1 in susceptibility to visceral leishmaniasis in India.","date":"2012","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22561395","citation_count":14,"is_preprint":false},{"pmid":"22015720","id":"PMC_22015720","title":"Cdx regulates Dll1 in multiple lineages.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22015720","citation_count":14,"is_preprint":false},{"pmid":"36935482","id":"PMC_36935482","title":"The phenotypic spectrum of terminal 6q deletions based on a large cohort derived from social media and literature: a prominent role for DLL1.","date":"2023","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36935482","citation_count":13,"is_preprint":false},{"pmid":"21742847","id":"PMC_21742847","title":"Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27.","date":"2011","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21742847","citation_count":13,"is_preprint":false},{"pmid":"20558326","id":"PMC_20558326","title":"Combination of in silico and in situ hybridisation approaches to identify potential Dll1 associated miRNAs during mouse embryogenesis.","date":"2010","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/20558326","citation_count":13,"is_preprint":false},{"pmid":"26923255","id":"PMC_26923255","title":"Mib1 modulates dynamin 2 recruitment via Snx18 to promote Dll1 endocytosis for efficient Notch signaling.","date":"2016","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/26923255","citation_count":12,"is_preprint":false},{"pmid":"26801181","id":"PMC_26801181","title":"Context-Dependent Sensitivity to Mutations Disrupting the Structural Integrity of Individual EGF Repeats in the Mouse Notch Ligand DLL1.","date":"2016","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26801181","citation_count":11,"is_preprint":false},{"pmid":"27188577","id":"PMC_27188577","title":"Disruption of Notch signaling aggravates irradiation-induced bone marrow injury, which is ameliorated by a soluble Dll1 ligand through Csf2rb2 upregulation.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27188577","citation_count":11,"is_preprint":false},{"pmid":"24167636","id":"PMC_24167636","title":"Normal development in mice over-expressing the intracellular domain of DLL1 argues against reverse signaling by DLL1 in vivo.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24167636","citation_count":10,"is_preprint":false},{"pmid":"34894355","id":"PMC_34894355","title":"Terminal 6q deletions cause brain malformations, a phenotype mimicking heterozygous DLL1 pathogenic variants: A multicenter retrospective case series.","date":"2021","source":"Prenatal diagnosis","url":"https://pubmed.ncbi.nlm.nih.gov/34894355","citation_count":9,"is_preprint":false},{"pmid":"19298012","id":"PMC_19298012","title":"Generation of transgenic mice expressing Cre recombinase under the control of the Dll1 mesoderm enhancer element.","date":"2009","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/19298012","citation_count":9,"is_preprint":false},{"pmid":"39444950","id":"PMC_39444950","title":"Cooperation of Wnt/β-catenin and Dll1-mediated Notch pathway in Lgr5-positive intestinal stem cells regulates the mucosal injury and repair in DSS-induced colitis mice model.","date":"2024","source":"Gastroenterology report","url":"https://pubmed.ncbi.nlm.nih.gov/39444950","citation_count":8,"is_preprint":false},{"pmid":"34439228","id":"PMC_34439228","title":"Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34439228","citation_count":8,"is_preprint":false},{"pmid":"32019397","id":"PMC_32019397","title":"The potential mechanism of miR-130b on promotion of the invasion and metastasis of hepatocellular carcinoma by inhibiting Notch-Dll1.","date":"2020","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/32019397","citation_count":8,"is_preprint":false},{"pmid":"38161194","id":"PMC_38161194","title":"LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo.","date":"2023","source":"Drug delivery and translational research","url":"https://pubmed.ncbi.nlm.nih.gov/38161194","citation_count":7,"is_preprint":false},{"pmid":"37149661","id":"PMC_37149661","title":"MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37149661","citation_count":7,"is_preprint":false},{"pmid":"34976140","id":"PMC_34976140","title":"miR-130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34976140","citation_count":7,"is_preprint":false},{"pmid":"33157082","id":"PMC_33157082","title":"Association of DLL1 with type 1 diabetes in patients characterized by low polygenic risk score.","date":"2020","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/33157082","citation_count":7,"is_preprint":false},{"pmid":"35371023","id":"PMC_35371023","title":"Dll1 Can Function as a Ligand of Notch1 and Notch2 in the Thymic Epithelium.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35371023","citation_count":6,"is_preprint":false},{"pmid":"24449764","id":"PMC_24449764","title":"S/T phosphorylation of DLL1 is required for full ligand activity in vitro but dispensable for DLL1 function in vivo during embryonic patterning and marginal zone B cell development.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24449764","citation_count":6,"is_preprint":false},{"pmid":"34385927","id":"PMC_34385927","title":"MALAT1: A Pivotal lncRNA in the Phenotypic Switch of Gastric Smooth Muscle Cells via the Targeting of the miR-449a/DLL1 Axis in Diabetic Gastroparesis.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34385927","citation_count":6,"is_preprint":false},{"pmid":"32901446","id":"PMC_32901446","title":"Tamoxifen Downregulates the Expression of Notch1 and DLL1 Genes in MKN-45 Gastric Cancer Cells.","date":"2021","source":"Journal of gastrointestinal cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32901446","citation_count":5,"is_preprint":false},{"pmid":"17672308","id":"PMC_17672308","title":"[Effect of mutation of chemotaxis signal transduction gene cheA in Pseudomonas putida DLL-1 on its chemotaxis and methyl parathion biodegradation].","date":"2007","source":"Wei sheng wu xue bao = Acta microbiologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/17672308","citation_count":5,"is_preprint":false},{"pmid":"28950865","id":"PMC_28950865","title":"Glioma cell fate decisions mediated by Dll1-Jag1-Fringe in Notch1 signaling pathway.","date":"2017","source":"BMC systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/28950865","citation_count":4,"is_preprint":false},{"pmid":"36590296","id":"PMC_36590296","title":"Dll1 haploinsufficiency causes brain abnormalities with functional relevance.","date":"2022","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36590296","citation_count":4,"is_preprint":false},{"pmid":"23769341","id":"PMC_23769341","title":"[Up-regulation of DLL1 may promote the chemotherapeutic sensitivity in small cell lung cancer].","date":"2013","source":"Zhongguo fei ai za zhi = Chinese journal of lung cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23769341","citation_count":4,"is_preprint":false},{"pmid":"30081298","id":"PMC_30081298","title":"Dll1 Marks Cells of Origin of Ras-Induced Cancer in Mouse Squamous Epithelia.","date":"2018","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30081298","citation_count":4,"is_preprint":false},{"pmid":"33559526","id":"PMC_33559526","title":"Computationally-obtained structural insights into the molecular interactions between Pidilizumab and binding partners DLL1 and PD-1.","date":"2021","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/33559526","citation_count":3,"is_preprint":false},{"pmid":"32703409","id":"PMC_32703409","title":"Localization of DLL1- and NICD-positive osteoblasts in cortical bone during postnatal growth in rats.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32703409","citation_count":3,"is_preprint":false},{"pmid":"38873849","id":"PMC_38873849","title":"Low-intensity pulsed ultrasound combined with ST36 modulate gastric smooth muscle contractile marker expression via RhoA/Rock and MALAT1/miR-449a/DLL1 signaling in diabetic rats.","date":"2024","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/38873849","citation_count":3,"is_preprint":false},{"pmid":"38626518","id":"PMC_38626518","title":"Novel small molecule DMAMCL induces differentiation in rhabdomyosarcoma by downregulating of DLL1.","date":"2024","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/38626518","citation_count":2,"is_preprint":false},{"pmid":"41129232","id":"PMC_41129232","title":"Differential O-glucose elongation on a specific EGF repeat within the canonical ligand-binding domain regulates DLL1/4-NOTCH1 signaling.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/41129232","citation_count":2,"is_preprint":false},{"pmid":"39904982","id":"PMC_39904982","title":"Usp11 maintained the survival of marginal zone B cells under ionizing radiation by deubiquitinating DLL1 and JAG2.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39904982","citation_count":2,"is_preprint":false},{"pmid":"22539391","id":"PMC_22539391","title":"[Expression of JAG1 and DLL1 genes in colorectal cancer and its clinical significance].","date":"2012","source":"Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery","url":"https://pubmed.ncbi.nlm.nih.gov/22539391","citation_count":2,"is_preprint":false},{"pmid":"28599454","id":"PMC_28599454","title":"Differential expression of the Notch1 receptor, and its ligands Dll1, Dll3 and Dll4 in distinct human pituitary adenoma subtypes.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28599454","citation_count":1,"is_preprint":false},{"pmid":"29444821","id":"PMC_29444821","title":"A fusion protein composed of the DSL domain of Dll1 and RGD motif protects cryptic stem cells in irradiation injury.","date":"2018","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/29444821","citation_count":1,"is_preprint":false},{"pmid":"30894800","id":"PMC_30894800","title":"Loss of Pax6 Causes Regional Changes in Dll1 Expression in Developing Cerebral Cortex.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30894800","citation_count":1,"is_preprint":false},{"pmid":"40775336","id":"PMC_40775336","title":"Soluble DLL1 as an Indicator of acute kidney injury and postoperative delirium following cardiac surgery: a secondary analysis of a prospective study.","date":"2025","source":"Perioperative medicine (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/40775336","citation_count":1,"is_preprint":false},{"pmid":"41191774","id":"PMC_41191774","title":"DLL1-responsive PD-L1+ tumor-associated macrophages promote endocrine resistance in breast cancer.","date":"2025","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41191774","citation_count":0,"is_preprint":false},{"pmid":"38772475","id":"PMC_38772475","title":"DLL1/NOTCH1 signaling pathway maintain angiogenesis in meniscus development and degeneration.","date":"2024","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/38772475","citation_count":0,"is_preprint":false},{"pmid":"34583743","id":"PMC_34583743","title":"Activity of the mouse Notch ligand DLL1 is sensitive to C-terminal tagging in vivo.","date":"2021","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/34583743","citation_count":0,"is_preprint":false},{"pmid":"39659197","id":"PMC_39659197","title":"GMNN and DLL1 mutation-related spondylocarpotarsal synostosis: a case report.","date":"2024","source":"Journal of Yeungnam medical science","url":"https://pubmed.ncbi.nlm.nih.gov/39659197","citation_count":0,"is_preprint":false},{"pmid":"40629898","id":"PMC_40629898","title":"A Serum DLL1 and CRP dual-marker model for bacterial infection detection in patients with decompensated cirrhosis: A dual-cohort diagnostic study.","date":"2025","source":"Science progress","url":"https://pubmed.ncbi.nlm.nih.gov/40629898","citation_count":0,"is_preprint":false},{"pmid":"41190327","id":"PMC_41190327","title":"DLL1 haploinsufficiency in prenatal brain anomalies: a retrospective analysis of 6q terminal deletions.","date":"2025","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41190327","citation_count":0,"is_preprint":false},{"pmid":"41861701","id":"PMC_41861701","title":"Discovery of guaianolide-eudesmanolide dimers as antihepatoma agents by targeting NEURL1B to disrupt the DLL1/Notch signaling pathway.","date":"2026","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41861701","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51226,"output_tokens":8762,"usd":0.142554,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18804,"output_tokens":4945,"usd":0.108823,"stage2_stop_reason":"end_turn"},"total_usd":0.251377,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"DLL1 is a mammalian transmembrane protein with tandem EGF-like repeats in its extracellular domain, closely related to Drosophila Delta, and functions as a ligand for Notch receptors in cell-to-cell signaling during embryogenesis, with expression in paraxial mesoderm and nervous system overlapping with Notch1.\",\n      \"method\": \"Molecular cloning, sequence analysis, in situ hybridization, expression mapping in mouse embryos\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original identification with multiple orthogonal methods (cloning, sequence, in situ hybridization), foundational paper replicated by entire field\",\n      \"pmids\": [\"7671806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"WNT signaling, acting through LEF/TCF transcription factors in cooperation with TBX6, directly activates transcription from the Dll1 promoter in the tailbud and presomitic mesoderm; mutating either T-box or LEF/TCF binding sites in the Dll1 promoter abolishes reporter gene expression in transgenic embryos.\",\n      \"method\": \"Promoter reporter assays in vitro, transgenic mouse embryo reporter analysis, genetic epistasis with Wnt pathway components\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — combined in vitro promoter assay and transgenic in vivo validation with site-directed mutagenesis\",\n      \"pmids\": [\"15545628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TBX6 directly binds to at least two of four putative Tbx6 binding sites within a Dll1 paraxial mesoderm enhancer in vitro, establishing Dll1 as a direct transcriptional target of Tbx6 in the presomitic mesoderm.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA) for Tbx6 DNA binding, transgenic mouse analysis, genetic interaction studies\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding assay plus genetic epistasis, single lab\",\n      \"pmids\": [\"15986483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MAGI1, a scaffolding molecule, directly binds DLL1 and recruits it to cadherin-based adherens junctions (AJs), stabilizing DLL1 on the cell surface; in cultured AJ-forming fibroblasts, MAGI1 localizes DLL1 to AJs through this direct protein-protein interaction.\",\n      \"method\": \"Co-immunoprecipitation, pulldown assays, immunolocalization in developing spinal cord and cultured fibroblasts, surface stability assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal binding assay with localization and functional surface-stability data, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"15908431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ubiquitination of DLL1 is not required for its endocytosis but is essential for recycling back to the cell surface; recycling is required for DLL1 to acquire high affinity for Notch1. A DLL1-DLL3 chimera (Dll1 ectodomain + Dll3 transmembrane/intracellular domain lacking lysines) can bind Notch1 but cannot induce transendocytosis of the Notch1 extracellular region, demonstrating that transendocytosis is required for Notch activation and depends on the DLL1 intracellular domain. DLL1 partially localizes to lipid microdomains, which are required for Notch signaling activation.\",\n      \"method\": \"Ubiquitination-defective DLL1 mutant analysis, chimeric DLL1-DLL3 construct, endocytosis/recycling assays, Notch1 binding assays, transendocytosis assay, lipid microdomain fractionation\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple complementary mechanistic constructs (ubiquitination mutant, chimeric ligand) with multiple orthogonal functional readouts in single rigorous study\",\n      \"pmids\": [\"18676613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DLL1 is an essential Notch ligand in fetal arterial endothelial cells that activates Notch1 to maintain arterial identity; in the absence of DLL1, VEGFR2 and NRP1 are downregulated and COUP-TFII (a repressor of arterial identity) is upregulated, revealing a DLL1→Notch1→VEGF pathway axis.\",\n      \"method\": \"Endothelial-specific conditional knockout mice, immunofluorescence, in situ hybridization, cell culture Notch reporter assays, Nrp1 promoter RBPJκ-site analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with defined molecular phenotype and pathway placement, multiple downstream markers examined\",\n      \"pmids\": [\"19144989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MT1-MMP (MMP14), expressed on bone marrow stromal cells, directly cleaves DLL1 on the cell surface, reducing Notch signaling in hematopoietic progenitor cells; this cleavage is required for normal B-lymphocyte development. Recombinant MT1-MMP cleaves a synthetic DLL1 peptide at the same site as on the cell surface.\",\n      \"method\": \"Co-culture of MT1-MMP-deficient BMSCs with hematopoietic progenitors, DAPT rescue experiments, Co-IP of MT1-MMP and DLL1, in vitro cleavage of synthetic DLL1 peptide by recombinant MT1-MMP, flow cytometry\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical cleavage assay with synthetic peptide plus co-IP interaction plus genetic rescue with Notch inhibitor, multiple orthogonal methods\",\n      \"pmids\": [\"21572390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DLL1 and DLL4 together are the physiological Notch ligands in the intestinal epithelium; simultaneous inactivation of both leads to complete conversion of proliferating progenitors into goblet cells and loss of intestinal stem cells (Olfm4+, Lgr5+, Ascl2+), while single DLL1 inactivation causes only a moderate increase in goblet cells without loss of stem cells.\",\n      \"method\": \"Inducible gut-specific conditional knockout mice (Vil-Cre-ERT2), lineage tracing, immunofluorescence, in situ hybridization\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional double-KO with well-defined cellular phenotype, single vs double mutant comparison establishes functional redundancy and necessity\",\n      \"pmids\": [\"21238454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DLL1 expression in the presomitic mesoderm is regulated by Cdx homeodomain transcription factors; Cdx members occupy the Dll1 promoter both in vivo (ChIP) and in vitro, and Cdx-Dll1 genetic interaction was confirmed in somitogenesis and goblet cell differentiation.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), promoter occupancy assays, Cdx conditional knockout mice, genetic interaction analysis\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus genetic interaction, single lab, two orthogonal methods\",\n      \"pmids\": [\"22015720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Elavl1/HuR binds to the 3' UTR of Dll1 mRNA in neuroepithelial cells during mitosis, stabilizing Dll1 mRNA; RNAi against Elavl1 reduces stability of Dll1-3'UTR-containing transcripts in mitosis-arrested cells and diminishes the capacity of brain precursors to trigger lateral inhibitory Notch signals to neighbors. Elavl1 heterozygous null mice show decreased Dll1 expression in developing brain.\",\n      \"method\": \"RNA immunoprecipitation (RIP), RNAi knockdown, mRNA stability assay, Elavl1 null-heterozygous mouse analysis, in vivo neurogenesis quantification in retina\",\n      \"journal\": \"Molecular Biology of the Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RIP demonstrating direct mRNA interaction, functional validation by RNAi, in vivo genetic model, multiple orthogonal methods\",\n      \"pmids\": [\"21346194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dll1 protein is induced in activated neural stem cells (NSCs) in the adult subventricular zone, segregates asymmetrically to one daughter cell during mitosis, and is required to maintain quiescent NSCs; Dll1-expressing cells reside in close proximity to quiescent NSCs, suggesting a feedback niche signal from progeny to parent stem cells.\",\n      \"method\": \"Conditional Dll1 knockout mice, live imaging, immunofluorescence for asymmetric protein segregation during mitosis, BrdU/EdU labeling, flow cytometry\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined cellular phenotype, direct live imaging of asymmetric segregation, multiple orthogonal methods\",\n      \"pmids\": [\"23695674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DLL4 but not DLL1 acts as an efficient cis-inhibitor of Notch signaling in cells co-expressing both ligand and receptor; both ligands have similar trans-activation potential, but the differential cis-inhibitory property of DLL4 contributes to context-dependent functional divergence. In vivo, endogenous Dll1 locus DLL4 knock-in mice show dominant somitogenesis defects.\",\n      \"method\": \"Notch transactivation co-culture assays in vitro, conditional overexpression from HPRT locus, DLL1-to-DLL4 knock-in mice (Dll1Dll4ki), vertebral column phenotype analysis\",\n      \"journal\": \"PLoS Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro Notch activation assays with defined mechanistic distinction (cis vs trans), plus multiple in vivo genetic models confirming context-dependent divergence\",\n      \"pmids\": [\"26114479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Serine and threonine phosphorylation sites in the intracellular domain of DLL1 were identified by mass spectrometry; phosphorylation requires membrane association and occurs sequentially, likely primed by protein kinase B. A phosphorylation-deficient DLL1 triple mutant is more stable but has reduced cell-surface levels, is more efficiently cleaved extracellularly, and activates Notch1 significantly less in co-culture assays. However, knock-in mice expressing the phosphorylation-deficient DLL1 develop normally, indicating compensation in vivo.\",\n      \"method\": \"Mass spectrometry phosphosite identification, site-directed mutagenesis, Notch1 co-culture activation assay, knock-in mouse generation, developmental phenotype analysis\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mass spectrometry identification plus mutagenesis plus in vitro functional assay plus in vivo knock-in, rigorous single study\",\n      \"pmids\": [\"24449764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Over-expression of the DLL1 intracellular domain (DICD) in mouse embryonic stem cells does not block proliferation or stimulate neuronal differentiation, and ubiquitous DICD expression in transgenic mice produces no developmental phenotype, normal Notch target gene expression, and viable fertile adults. Mouse DICD enters the nucleus inefficiently, arguing against a reverse signaling function of the DLL1 intracellular domain in vivo.\",\n      \"method\": \"Transgenic mouse generation with ubiquitous DICD expression, ES cell transfection, Notch target gene analysis, nuclear localization assay\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — rigorous in vivo transgenic test of a specific mechanistic hypothesis (reverse signaling) with negative conclusion, multiple readouts\",\n      \"pmids\": [\"24167636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Each individual EGF repeat in the extracellular domain of DLL1 is required for full Notch transactivation activity; mutations disrupting disulfide bridges in each EGF repeat reduce DLL1 activity toward both NOTCH1 and NOTCH2 in co-culture assays. In vivo, an allelic series of knock-in mice shows context-dependent sensitivity: some EGF repeat mutations affect only somite patterning (resembling spondylocostal dysostosis) while others affect multiple processes.\",\n      \"method\": \"EGF-repeat mutagenesis, HPRT single-copy transgene expression, Notch co-culture transactivation assay, knock-in mouse allelic series, vertebral column phenotyping\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis of all EGF repeats in vitro plus comprehensive in vivo allelic series, multiple orthogonal methods\",\n      \"pmids\": [\"26801181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Mib1 ubiquitin ligase promotes the interaction between dynamin 2 and Snx18 in a ubiquitin ligase activity-dependent manner, thereby facilitating dynamin 2 recruitment to DLL1 and promoting DLL1 endocytosis and Notch signaling efficiency.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitin ligase activity-dependent protein interaction assay, endocytosis assay for DLL1\",\n      \"journal\": \"Genes to Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP and functional endocytosis data, single lab, single paper\",\n      \"pmids\": [\"26923255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SYNJ2BP (synaptojanin-2 binding protein) interacts with the PDZ binding motif of DLL1 (and DLL4) intracellular domain, but not with Jagged-1, enhances DLL1 protein stability, promotes Notch signaling in endothelial cells, and inhibits tip cell formation and sprouting angiogenesis.\",\n      \"method\": \"Yeast two-hybrid, Co-IP, DLL1/DLL4 protein stability assay, Notch target gene expression analysis, endothelial cell functional assays (migration, proliferation), in vivo vascular density in immunocompromised mice\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding interaction identified and functional consequence on DLL1 stability demonstrated with multiple in vitro and in vivo readouts, single lab\",\n      \"pmids\": [\"24025447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DLL1 is enriched in mammary gland stem cells (MaSCs) and mediates cross-talk with stromal macrophages; MaSC-expressed DLL1 activates Notch signaling in macrophages, increasing their expression of Wnt3, Wnt10A, and Wnt16, which feeds back to promote DLL1-expressing MaSC function. Conditional deletion of Dll1 reduced MaSC numbers and impaired ductal morphogenesis.\",\n      \"method\": \"Conditional Dll1 knockout mice, mammary transplantation assay, immunofluorescence, flow cytometry, Wnt ligand expression analysis in macrophages, co-culture experiments\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined cellular phenotype, identification of downstream pathway (Wnt ligands in macrophages), multiple orthogonal methods, high-impact venue\",\n      \"pmids\": [\"29773667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Estrogen signaling stabilizes DLL1 protein by preventing its proteasomal and lysosomal degradation and inhibiting DLL1 ubiquitination in ERα+ breast cancer cells.\",\n      \"method\": \"Proteasomal/lysosomal inhibitor treatment, ubiquitination assay, DLL1 protein stability assay, DLL1 conditional knockout in breast cancer mouse models\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ubiquitination assay and pharmacological inhibitor experiments, single lab, two orthogonal methods\",\n      \"pmids\": [\"30442981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DLL1 ectodomains dictate selective Notch receptor activation: DLL4 preferentially activates NOTCH1 over NOTCH2, whereas DLL1 is equally effective in activating NOTCH1 and NOTCH2. The discriminating potential lies in the region between the N-terminus and EGF repeat 3. In vivo, ectodomains dictate ligand function during somitogenesis, while during myogenesis even regions C-terminal to EGF3 are interchangeable.\",\n      \"method\": \"Chimeric DLL1/DLL4 ligand analysis, cellular co-culture Notch activation assays, biochemical binding studies, chimeric knock-in mice analysis in vivo\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic chimeric ligand approach combined with biochemical binding studies and in vivo genetic validation, multiple orthogonal methods\",\n      \"pmids\": [\"30289388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MyoD directly activates transcription of Dll1 via E-box motifs in its regulatory region; Dll1 in turn activates Notch signaling in neighboring myoblasts (trans-activation) to prevent premature differentiation, while autonomously inhibiting Notch in Dll1-expressing cells to facilitate their own myogenic program. This MyoD-Dll1-Notch axis was validated by E-box mutant knock-in mice and CRISPR interference in human cells.\",\n      \"method\": \"ChIP for MyoD at Dll1 locus, E-box mutant knock-in mouse model, CRISPR-mediated interference, gain/loss-of-function studies in mouse and human cells, Notch reporter assays\",\n      \"journal\": \"PLoS Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — ChIP, mutagenesis, in vivo knock-in, and human cell CRISPR validation across multiple orthogonal methods\",\n      \"pmids\": [\"34370738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DLL1+ tumor cells activate Notch signaling in cancer-associated fibroblasts (CAFs), which increases Wnt ligand secretion from CAFs, leading to β-catenin-driven radioresistance and metastasis in breast cancer.\",\n      \"method\": \"Conditional Dll1 knockout and reporter mouse models, co-culture experiments, RNA-seq, ATAC-seq, pharmacological Notch/Wnt pathway inhibition\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mouse plus transcriptomic evidence plus pathway rescue experiments, single lab\",\n      \"pmids\": [\"36007109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DLL1+ breast cancer tumor cells drive a chemoresistant phenotype via NF-κB activation downstream of DLL1; RNA-seq and ATAC-seq using reporter models and patient data showed NF-κB activation is downstream of DLL1. Pharmacological blocking of DLL1 or NF-κB completely sensitizes Dll1+ tumors to chemotherapy.\",\n      \"method\": \"Conditional Dll1 knockout and reporter mouse models, RNA-seq, ATAC-seq, NF-κB pathway inhibition, pharmacological DLL1 blockade\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with multi-omic pathway analysis, pharmacological rescue, single lab\",\n      \"pmids\": [\"33462238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"APE1 redox function activates NF-κB, which directly binds to and induces expression of DLL1 in esophageal adenocarcinoma cells in response to acidic bile salts (reflux conditions); elevated DLL1 then activates NOTCH1 signaling, promoting cancer stem-like properties.\",\n      \"method\": \"NF-κB binding to DLL1 promoter (ChIP), APE1 redox inhibitor experiments, DLL1 knockdown, Notch reporter assays, in vitro and transgenic mouse model validation\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP identifies direct NF-κB binding to DLL1 promoter, functional rescue experiments, single lab\",\n      \"pmids\": [\"35750470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HUWE1 E3 ubiquitin ligase ubiquitinates and degrades N-Myc, which acts as a transcriptional activator of DLL1; thus HUWE1 suppresses the N-Myc→DLL1→NOTCH1 signaling axis to inhibit glioblastoma cell proliferation and invasion.\",\n      \"method\": \"Co-IP, ubiquitination assays, dCas9 synergistic activation, recombinant AAV-mediated HUWE1 overexpression, in vitro and orthotopic xenograft tumor models\",\n      \"journal\": \"Cancer Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ubiquitination assay plus pathway epistasis plus in vivo xenograft, single lab\",\n      \"pmids\": [\"35848447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Dll1 expressed in the thymic epithelium can completely restore T-cell development in Dll4-deficient mice; Dll1 activates both NOTCH1 and NOTCH2 receptors to support T-cell development, in contrast to Dll4 which signals exclusively through NOTCH1 in the thymic environment.\",\n      \"method\": \"Foxn1-Cre conditional Dll4-knockout mice with Dll1 conditional transgenic rescue, bone marrow chimeras with Notch1- or Notch2-deficient hematopoietic cells, flow cytometry\",\n      \"journal\": \"Frontiers in Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue experiment with conditional transgene plus receptor-specific chimera experiments, multiple orthogonal in vivo methods\",\n      \"pmids\": [\"35371023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Site-specific O-glucose glycan elongation on NOTCH1 EGF10 (with hexose and Neu5Ac forming a 3'-sialyllactose-like structure, synthesized by B4GALT1 and ST3GAL4) significantly impacts DLL1- and DLL4-dependent NOTCH1 ligand binding and signal transduction; C4-2 position amino acid in the EGF domain is crucial for galactose elongation.\",\n      \"method\": \"Mass spectrometry glycan identification, mutagenesis (C4-2 position), Notch signaling assays, early T-cell development functional assays\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — mass spectrometry + mutagenesis + functional assay, single lab, novel finding not yet independently replicated\",\n      \"pmids\": [\"41129232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Usp11 deubiquitinase sustains survival of marginal zone B cells by regulating ubiquitination of Notch ligands DLL1 and JAG2; Co-IP and ubiquitination experiments demonstrated that Usp11 physically interacts with DLL1 and JAG2 and prevents their ubiquitin-mediated degradation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, Usp11-/- knockout mice, flow cytometry, single-cell RNA sequencing\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus KO mouse model, single lab\",\n      \"pmids\": [\"39904982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DLL1 recruits immunosuppressive PD-L1+ tumor-associated macrophages through the CCR3/CCL7 axis; tumor cell DLL1-mediated Notch signaling in macrophages maintains cancer stem cell activity. Combination of anti-DLL1 and anti-PD-L1 antibodies with tamoxifen reduced tumor growth and reprogrammed the immunosuppressive tumor microenvironment in mouse models and patient-derived explants.\",\n      \"method\": \"Conditional knockout mouse models, new immunocompetent breast cancer mouse models, antibody blockade experiments, patient-derived explants, flow cytometry, tumor growth analysis\",\n      \"journal\": \"Science Translational Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO plus antibody blockade plus patient-derived explant validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"41191774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DLL1 mediates Notch activation across expression domain boundaries in the spinal cord (can signal to progenitors outside its own expression domain), whereas JAG1 can only activate Notch within V1 and dI6 progenitor domains; double Dll1;Jag1 conditional knockout embryos show stronger neurogenic phenotypes than single mutants, confirming functional compensation by Dll1 for Jag1 loss.\",\n      \"method\": \"Single and double conditional knockout mice (neuroepithelium-specific), neuronal subtype quantification, genetic epistasis\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional single and double KO comparison establishing differential spatial signaling range, multiple domain analysis\",\n      \"pmids\": [\"21124801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DLL1-mediated Notch signaling in osteoblasts promotes proliferation of committed but immature osteoblasts while inhibiting their further differentiation into mature functional osteoblasts; osteoblast-specific DLL1 transgenic mice show severe suppression of bone metabolic turnover due to maturational arrest of osteoblasts impairing osteoblast-osteoclast coupling.\",\n      \"method\": \"Osteoblast-specific DLL1 transgenic mice, bone histomorphometry, osteoblast and osteoclast differentiation assays, bone remodeling marker analysis\",\n      \"journal\": \"Journal of Cellular Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — osteoblast-specific transgenic overexpression with defined cellular and tissue phenotype, single lab\",\n      \"pmids\": [\"27735989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DLL1 activates Notch signaling predominantly through the Notch2 receptor in multiple myeloma cells on bone marrow stromal cells, and this signaling upregulates CYP1A1 (a drug-metabolizing cytochrome P450 enzyme) as a mechanism of bortezomib resistance; CYP1A1 inhibition or siRNA restored bortezomib sensitivity.\",\n      \"method\": \"Co-culture of myeloma cells with Dll1-expressing stromal cells, Notch receptor-specific analysis, CYP1A1 siRNA knockdown, pharmacological inhibition (α-naphthoflavone), in vivo 5T33MM mouse model\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor specificity analysis, siRNA rescue, and in vivo validation, single lab\",\n      \"pmids\": [\"23111325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Arp2/3 complex is required for DLL1 vesicular transport from cytoplasm to cell membrane; inhibition of Arp2/3 impedes DLL1 trafficking to the cell surface, preventing DLL1-mediated Notch1 activation and the maintenance of stem cell phenotype in glioma initiating cells.\",\n      \"method\": \"shRNA knockdown of DLL1 and Arp2/3 components, exogenous soluble DLL1 rescue experiment, vesicular transport imaging, CD133+ cell functional assays, intracranial xenograft model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — shRNA epistasis plus rescue with soluble DLL1, single lab, mechanistic interpretation of trafficking requirement\",\n      \"pmids\": [\"28380416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"C-terminal tagging of DLL1 protein with AcGFPHA or Strep/FLAG tags impairs DLL1 activity in vivo, causing vertebral column defects in homozygous knock-in mice, demonstrating that even small C-terminal additions can reduce DLL1 function during sensitive developmental processes such as somitogenesis.\",\n      \"method\": \"Endogenous knock-in tagging by homologous recombination, developmental phenotype analysis, Western blot protein detection, CHO cell functional assay\",\n      \"journal\": \"BMC Research Notes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vivo knock-in with phenotypic readout, single lab, single paper establishing practical mechanistic constraint\",\n      \"pmids\": [\"34583743\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DLL1 is a transmembrane Notch ligand whose extracellular EGF repeats (especially N-terminus to EGF3) engage NOTCH1 and NOTCH2 with equal potency (unlike DLL4 which preferentially activates NOTCH1); its activity depends on ubiquitination-driven endocytic recycling to acquire receptor-binding competency, correct vesicular trafficking to the plasma membrane (requiring Arp2/3), stabilization at adherens junctions via MAGI1 and PDZ-domain partners such as SYNJ2BP, and sequential intracellular phosphorylation primed by protein kinase B; extracellular shedding is negatively regulated by MT1-MMP cleavage; mRNA stability is controlled by HuR/Elavl1 during mitosis; DLL1 transcription is directly activated by WNT/LEF-TCF cooperating with TBX6/Tbx6, by Cdx factors, by MyoD (in muscle), and by NF-κB, while being post-translationally stabilized by estrogen (inhibiting ubiquitination) and destabilized by NEURL1B/Mib1-mediated ubiquitination and by Usp11-dependent deubiquitination; acting as a ligand it drives lateral inhibition and binary cell-fate decisions in diverse tissues (intestine, neural, vascular, muscle, pancreas, inner ear), activating downstream Hes/Hey targets through Notch1/2 in a context-dependent manner that is further modulated by O-glucose glycan elongation on NOTCH1 EGF10.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DLL1 is a mammalian transmembrane Notch ligand whose extracellular EGF-like repeats engage Notch receptors to drive cell-to-cell signaling and binary cell-fate decisions across many embryonic and adult tissues [#0]. Its ectodomain dictates receptor selectivity: the region between the N-terminus and EGF repeat 3 confers the ability to activate NOTCH1 and NOTCH2 with equal efficiency, distinguishing it from DLL4 which preferentially activates NOTCH1, and each individual EGF repeat is required for full transactivation of both receptors [#14, #19]. Productive signaling requires DLL1 to be made receptor-binding competent: ubiquitination drives endocytic recycling needed to acquire high affinity for NOTCH1, and ligand-pulling transendocytosis of the Notch ectodomain depends on the DLL1 intracellular domain [#4]. Surface availability and stability are tuned through trafficking and turnover—Arp2/3-dependent vesicular transport to the membrane [#32], MAGI1-mediated recruitment to adherens junctions [#3], SYNJ2BP binding to its PDZ motif [#16], sequential intracellular phosphorylation primed by protein kinase B [#12], MT1-MMP ectodomain shedding [#6], and competing ubiquitination/deubiquitination by Mib1 and Usp11 [#15, #27]—whereas the intracellular domain does not mediate a reverse-signaling function in vivo [#13]. DLL1 transcription is directly activated by WNT/LEF-TCF cooperating with TBX6, by Cdx factors, by MyoD in muscle, and by NF-\\u03baB, while HuR/Elavl1 stabilizes its mRNA during mitosis [#1, #8, #20, #23, #9]. Functionally, DLL1 maintains intestinal and neural stem cells, arterial endothelial identity, T-cell development, and stem-cell/niche cross-talk, and partial loss-of-function mutations in EGF repeats produce somite-patterning defects resembling spondylocostal dysostosis [#7, #10, #5, #25, #14].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established DLL1 as a mammalian transmembrane Notch ligand, answering whether the Drosophila Delta paradigm extends to vertebrate development.\",\n      \"evidence\": \"Molecular cloning, sequence analysis, and in situ hybridization in mouse embryos\",\n      \"pmids\": [\"7671806\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which Notch receptor(s) DLL1 preferentially activates\", \"No mechanism of ligand activation or trafficking defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified how DLL1 expression is positioned in the presomitic mesoderm by showing WNT/LEF-TCF cooperates with TBX6 to directly drive the Dll1 promoter.\",\n      \"evidence\": \"Promoter reporter assays plus transgenic mouse embryo reporters with site-directed mutagenesis of T-box and LEF/TCF sites\",\n      \"pmids\": [\"15545628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific enhancers outside PSM not addressed\", \"Did not establish direct TBX6 DNA contacts\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Confirmed direct TBX6 binding to a Dll1 enhancer and identified MAGI1 as a junctional scaffold that stabilizes DLL1 at the cell surface, linking transcriptional control and surface presentation.\",\n      \"evidence\": \"EMSA for TBX6 binding; Co-IP, pulldown, immunolocalization, and surface-stability assays for MAGI1\",\n      \"pmids\": [\"15986483\", \"15908431\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"MAGI1 effect on signaling output not quantified\", \"Single-lab findings\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the activation mechanism by showing ubiquitination-driven recycling makes DLL1 receptor-binding competent and that intracellular-domain-dependent transendocytosis is required for Notch activation.\",\n      \"evidence\": \"Ubiquitination-defective and DLL1-DLL3 chimeric constructs with endocytosis/recycling, binding, transendocytosis, and lipid microdomain assays\",\n      \"pmids\": [\"18676613\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the recycling-dependent affinity change unresolved\", \"Specific ubiquitin ligase not yet assigned in this study\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Placed DLL1 in a tissue pathway by showing it activates NOTCH1 to maintain arterial endothelial identity through downstream VEGF/NRP1 and COUP-TFII control.\",\n      \"evidence\": \"Endothelial-specific conditional knockout mice with immunofluorescence, in situ, and Notch reporter assays\",\n      \"pmids\": [\"19144989\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of all downstream markers not fully separated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Distinguished DLL1 signaling range, showing it can activate Notch across expression-domain boundaries in the spinal cord and compensate for JAG1 loss.\",\n      \"evidence\": \"Single and double neuroepithelium-specific conditional knockouts with neuronal subtype quantification\",\n      \"pmids\": [\"21124801\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for differential signaling range vs JAG1 unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapped multiple regulatory inputs and tissue roles: Cdx transcriptional control, HuR-mediated mitotic mRNA stabilization, MT1-MMP shedding, and redundancy with DLL4 in intestinal stem-cell maintenance.\",\n      \"evidence\": \"ChIP and Cdx KO; RIP and Elavl1 mouse; MT1-MMP co-IP and synthetic-peptide cleavage; inducible gut-specific double KO with lineage tracing\",\n      \"pmids\": [\"22015720\", \"21346194\", \"21572390\", \"21238454\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay among these regulatory layers not integrated\", \"Cdx and shedding findings are single-lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Resolved whether the intracellular domain signals in reverse and revealed asymmetric DLL1 segregation in neural stem cells, plus SYNJ2BP as a stabilizing PDZ partner.\",\n      \"evidence\": \"Ubiquitous DICD transgenic mice and nuclear-localization assays; conditional Dll1 KO with live imaging; yeast two-hybrid and stability assays for SYNJ2BP\",\n      \"pmids\": [\"24167636\", \"23695674\", \"24025447\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DICD result is a negative in vivo conclusion that does not exclude subtle context-specific roles\", \"SYNJ2BP finding single-lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked surface stability, shedding, and phosphorylation, and separated cis-inhibition from trans-activation as a source of DLL1/DLL4 functional divergence.\",\n      \"evidence\": \"Mass spectrometry phosphosite mapping with mutants and knock-in mice; transactivation co-culture and DLL1-to-DLL4 knock-in mice\",\n      \"pmids\": [\"24449764\", \"26114479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phospho-deficient mice develop normally, indicating in vivo compensation not understood\", \"Kinase identity (PKB priming) inferred, not directly proven\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined ectodomain structure-function by showing every EGF repeat contributes to activity and that Mib1 promotes DLL1 endocytosis via dynamin-2/Snx18 recruitment.\",\n      \"evidence\": \"Systematic EGF-repeat mutagenesis with knock-in allelic series; Co-IP and endocytosis assays for Mib1/dynamin-2/Snx18\",\n      \"pmids\": [\"26801181\", \"26923255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How individual EGF repeats map to receptor contacts not structurally resolved\", \"Mib1/Snx18 mechanism single-lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established trafficking and tissue requirements: Arp2/3-dependent vesicular transport to the surface, and DLL1-Notch control of osteoblast maturation.\",\n      \"evidence\": \"shRNA epistasis with soluble-DLL1 rescue and transport imaging; osteoblast-specific transgenic mice with histomorphometry\",\n      \"pmids\": [\"28380416\", \"27735989\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Arp2/3 requirement inferred from trafficking block, mechanism indirect\", \"Osteoblast phenotype from overexpression, not loss-of-function\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined receptor-selectivity determinants in the ectodomain and identified estrogen and stem-cell niche cross-talk as regulators of DLL1 stability and function.\",\n      \"evidence\": \"Chimeric ligand and biochemical binding studies with knock-in mice; ubiquitination/stability assays in ER\\u03b1+ cells; conditional KO with mammary transplantation and macrophage co-culture\",\n      \"pmids\": [\"30289388\", \"30442981\", \"29773667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Estrogen-to-ubiquitination link mechanistic intermediary unknown\", \"Selectivity element between N-terminus and EGF3 not structurally mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified MyoD as a direct muscle transcriptional activator of Dll1 and characterized DLL1 cancer roles driving NF-\\u03baB chemoresistance and CAF-mediated Wnt/\\u03b2-catenin radioresistance.\",\n      \"evidence\": \"ChIP, E-box mutant knock-in mice, and CRISPRi in human cells; conditional KO/reporter mice with RNA-seq, ATAC-seq, and pharmacological pathway inhibition\",\n      \"pmids\": [\"34370738\", \"33462238\", \"36007109\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NF-\\u03baB and CAF cancer mechanisms single-lab\", \"Directness of NF-\\u03baB activation downstream of DLL1 not fully dissected\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Expanded the regulatory network with NF-\\u03baB/APE1 and N-Myc/HUWE1 transcriptional control of DLL1, and showed DLL1 supports T-cell development via both NOTCH1 and NOTCH2.\",\n      \"evidence\": \"ChIP and redox-inhibitor experiments; Co-IP and ubiquitination assays with xenografts; conditional Dll4 KO with Dll1 rescue and Notch-receptor-deficient chimeras\",\n      \"pmids\": [\"35750470\", \"35848447\", \"35371023\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cancer transcriptional axes single-lab\", \"Receptor-usage context dependence not mechanistically explained\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected NOTCH1 glycosylation to ligand binding and added Usp11 deubiquitination and immunosuppressive macrophage recruitment to the DLL1 functional repertoire.\",\n      \"evidence\": \"Mass spectrometry glycan mapping with mutagenesis; Co-IP/ubiquitination assays with Usp11 KO mice; conditional KO with antibody blockade and patient-derived explants\",\n      \"pmids\": [\"41129232\", \"39904982\", \"41191774\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Glycan finding not independently replicated\", \"Usp11 and macrophage-axis findings single-lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple post-translational layers (recycling, phosphorylation, shedding, competing ubiquitination/deubiquitination) are integrated to set DLL1 signaling output in a given cell, and the structural basis of ectodomain receptor selectivity, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated quantitative model of DLL1 surface activation\", \"No structure of DLL1 ectodomain bound to NOTCH1 vs NOTCH2\", \"Compensation masking phospho-mutant phenotypes in vivo unexplained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 14, 19]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 4, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 4, 32]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 5, 7, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 25]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NOTCH1\", \"NOTCH2\", \"MAGI1\", \"SYNJ2BP\", \"MMP14\", \"MIB1\", \"USP11\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}